3i Group Has Agreed to Invest in Cirtec Medical

July 11, 2017

3i Group plc (“3i”) has agreed to invest in Cirtec Medical (“Cirtec”), a leading provider of outsourced design, engineering and manufacturing for active implantable medical devices.

3i Group retained Cain Brothers as exclusive financial advisor in conjunction with the transaction.

For over 25 years, Cirtec has been providing design, development, manufacturing and product transfer services for the medical device industry. With facilities in Los Gatos, CA, Enfield, CT and Brooklyn Park, MN, the Company specializes in outsourced solutions for active implantable devices in the areas of neuromodulation, drug delivery, cardiac rhythm management, ventricular assist, and minimally invasive devices.

3i is an investment company with two complementary businesses, Private Equity and Infrastructure, specializing in core investment markets in North America and Northern Europe. 3i’s Private Equity team provides investment solutions for growing companies, backing entrepreneurs and management teams of mid-market companies with an EV typically between $100m – $500m. 3i’s Private Equity business operates across 8 countries globally and has invested in hundreds of businesses worldwide across the industrials, consumer and business and technology services industries. 3i backs international growth plans, providing access to its network and expertise to accelerate growth.

For more information, please contact:

John V. Soden

Managing Director
(415) 962-2922
jsoden@cainbrothers.com

Rafe B. Hanahan

Managing Director
(415) 962-2960
rhanahan@cainbrothers.com